Zhang Cheng-li

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

Shun Lü, Lin Wu, Hong Jian et al. · The Lancet Oncology · 2022 · 227 citations

Oncology, First Interim Results, Bevacizumab Biosimilar Ibi305 +10

Sorption of organochlorine pesticides on polyethylene microplastics in soil suspension

Zhang Cheng-li, Yuchen Lei, Jing Qian et al. · Ecotoxicology and Environmental Safety · 2021 · 77 citations · Full text

Protic ionic liquid derived nitrogen/sulfur-codoped carbon materials as high-performance electrodes for supercapacitor

Li Sun, Hua Zhou, Yonghong Li et al. · Materials Letters · 2016 · 18 citations

Materials Science, Supercapacitors, Engineering +10

Thallium pollution and potential ecological risk in the vicinity of coal mines in Henan Province, China

Zhang Cheng-li · Chemical Speciation and Bioavailability · 2018 · 12 citations · Full text